[ad_1]
Rebound for the Bayer subsidiary.
WASHINGTON (AFP). The legal problems of the Bayer Monsanto subsidiary in the United States due to Roundup herbicide with controversial glyphosate are expanding. A federal judge in San Francisco admitted over 400 complaints on Tuesday about the possible carcinogenic effects of the drug – about three weeks after the first cancer patient attacked Monsanto.
Thousands of cancer patients in the United States Suffering responsible. Farmers, gardeners and other Roundup users accuse the group of obscuring the carcinogenic effects of the product. Monsanto, which has been part of Bayer since June, challenges the link between glyphosate and cancer. The company relies on "more than 800 scientific studies". In the ongoing trial in San Francisco, former school janitor Dewayne Johnson, who suffers from a non-Hodgkin's lymphoma (NHL) terminally, complains of a form of lymphoma cancer. The decision is expected for the summer.
At the same time, another California judge in recent weeks, at Monsanto's request, has handled more than 400 other cases for NHL diseases in order to reject and prevent lawsuits. However, Judge Vince Chhabria broke the demand. Although the evidence is "too ambiguous" to allow the clear conclusion that glyphosate is a trigger of the NHL, then the judge. Nevertheless, it was possible that the jury found in a process that the link between the disease and the remedy was sufficiently proven. Chhabria described this as a "formidable challenge" for claimants to prove this. Bayer bought Monsanto in early June for $ 63 billion.
!
[ad_2]
Source link
